Is NRO.PA undervalued or overvalued?
As of 2025-03-26, the Intrinsic Value of Neurones SA (NRO.PA) is 34.16 EUR. This NRO.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 49.05 EUR, the upside of Neurones SA is -30.40%. This means that NRO.PA is overvalued by 30.40%.
The range of the Intrinsic Value is 25.83 - 51.95 EUR
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 25.83 - 51.95 | 34.16 | -30.4% |
DCF (Growth 10y) | 33.33 - 64.66 | 43.40 | -11.5% |
DCF (EBITDA 5y) | 27.73 - 42.80 | 32.87 | -33.0% |
DCF (EBITDA 10y) | 33.71 - 52.06 | 40.19 | -18.1% |
Fair Value | 28.45 - 28.45 | 28.45 | -42.00% |
P/E | 49.94 - 53.35 | 53.15 | 8.4% |
EV/EBITDA | 22.93 - 44.34 | 34.09 | -30.5% |
EPV | 91.49 - 124.11 | 107.80 | 119.8% |
DDM - Stable | 16.29 - 44.56 | 30.42 | -38.0% |
DDM - Multi | 29.67 - 59.87 | 39.35 | -19.8% |
Market Cap (mil) | 1,190.93 |
Beta | 0.59 |
Outstanding shares (mil) | 24.28 |
Enterprise Value (mil) | 1,190.93 |
Market risk premium | 5.82% |
Cost of Equity | 8.31% |
Cost of Debt | 5.00% |
WACC | 8.14% |